BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7473135)

  • 21. Cannabinoid ligand-receptor signaling in the mouse uterus.
    Das SK; Paria BC; Chakraborty I; Dey SK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.
    Hampson AJ; Hill WA; Zan-Phillips M; Makriyannis A; Leung E; Eglen RM; Bornheim LM
    Biochim Biophys Acta; 1995 Nov; 1259(2):173-9. PubMed ID: 7488638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anandamide, a naturally-occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction.
    Van der Kloot W
    Brain Res; 1994 Jun; 649(1-2):181-4. PubMed ID: 7953630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.
    Goparaju SK; Ueda N; Yamaguchi H; Yamamoto S
    FEBS Lett; 1998 Jan; 422(1):69-73. PubMed ID: 9475172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis.
    Matias I; Bisogno T; Melck D; Vandenbulcke F; Verger-Bocquet M; De Petrocellis L; Sergheraert C; Breton C; Di Marzo V; Salzet M
    Brain Res Mol Brain Res; 2001 Mar; 87(2):145-59. PubMed ID: 11245916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and characterization of endogenous cannabinoids.
    Martin BR; Mechoulam R; Razdan RK
    Life Sci; 1999; 65(6-7):573-95. PubMed ID: 10462059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland.
    Busch L; Sterin-Borda L; Borda E
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):258-63. PubMed ID: 16487271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups.
    Berglund BA; Boring DL; Wilken GH; Makriyannis A; Howlett AC; Lin S
    Prostaglandins Leukot Essent Fatty Acids; 1998 Aug; 59(2):111-8. PubMed ID: 9774174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol].
    Waku K
    Yakugaku Zasshi; 2006 Feb; 126(2):67-81. PubMed ID: 16462096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.
    Khanolkar AD; Abadji V; Lin S; Hill WA; Taha G; Abouzid K; Meng Z; Fan P; Makriyannis A
    J Med Chem; 1996 Oct; 39(22):4515-9. PubMed ID: 8893848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the synthesis of endocannabinoid related ligands.
    Razdan RK; Mahadevan A
    Chem Phys Lipids; 2002 Dec; 121(1-2):21-33. PubMed ID: 12505687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid receptors and their endogenous ligands.
    Sugiura T; Waku K
    J Biochem; 2002 Jul; 132(1):7-12. PubMed ID: 12097154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of CB1 mRNA upon activation of murine splenocytes.
    Noe SN; Newton C; Widen R; Friedman H; Klein TW
    Adv Exp Med Biol; 2001; 493():215-21. PubMed ID: 11727768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
    Koh WS; Crawford RB; Kaminski NE
    Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.
    Ng EW; Aung MM; Abood ME; Martin BR; Razdan RK
    J Med Chem; 1999 Jun; 42(11):1975-81. PubMed ID: 10354405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors.
    Ishii I; Chun J
    Neuroreport; 2002 Apr; 13(5):593-6. PubMed ID: 11973452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.
    Sipe JC; Arbour N; Gerber A; Beutler E
    J Leukoc Biol; 2005 Jul; 78(1):231-8. PubMed ID: 15845647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity.
    Sido JM; Nagarkatti PS; Nagarkatti M
    Eur J Immunol; 2016 Jun; 46(6):1472-9. PubMed ID: 27064137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development.
    Wang J; Paria BC; Dey SK; Armant DR
    Biol Reprod; 1999 Apr; 60(4):839-44. PubMed ID: 10084956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anandamide prior to sensitization increases cell-mediated immunity in mice.
    Ribeiro A; Ferraz-de-Paula V; Pinheiro ML; Sakai M; Costa-Pinto FA; Palermo-Neto J
    Int Immunopharmacol; 2010 Apr; 10(4):431-9. PubMed ID: 20093200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.